Development of hamlet as a adjuvant for the treatment of drug-resistant staphylococcus aureus infections
Ended Project Grant Awarded Last action
- Award ID
- R21AI121614
- Recipient
-
Cubrc, Inc. UEI M5T9V4YAGNM5
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $397,896
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Place of performance
- Cheektowaga, NY 14225, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $198,948 | |
| Original award | $198,948 |
Quick answers
Who received award R21AI121614?
R21AI121614 was awarded to Cubrc, Inc. by National Institutes of Health (Department of Health and Human Services) on December 1, 2015.
How much is award R21AI121614 worth?
$397,896 has been obligated on R21AI121614.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award